Open AccessThe efficacy and safety of simultaneous integrated boost intensity-modulated radiation therapy for esophageal squamous cell carcinoma in Chinese population: A single institution experience
Author(s) -
Yujin Xu,
Zhun Wang,
Liu Guan,
Zheng Xiao,
Yuezhen Wang,
Wei Feng,
Xiaojing Lai,
Xia Zhou,
Pu Li,
Hu Ma,
Jin Wang,
Xiao Hu,
Ming Chen
Publication year - 2016
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.191640
Subject(s) - medicine , common terminology criteria for adverse events , response evaluation criteria in solid tumors , radiation therapy , chemoradiotherapy , oncology , chemotherapy , population , progressive disease , carcinoma , adverse effect , environmental health
To evaluate the clinical efficacy and toxicity of simultaneous integrated boost intensity-modulated radiotherapy (SIB-IMRT) in patients with esophageal squamous cell carcinoma (ESCC) in Chinese population.